BDD is a supplier to the pharmaceutical industry that offers Lean Clinical Development, a process designed to disrupt and streamline the traditional early drug development approach, thereby accelerating timelines and reducing waste. By integrating phase-appropriate development with “just in time” manufacturing and clinical agility, BDD delivers the fastest path to phase I data, providing clients with a competitive edge. As a combined site, Contract Research Organisation (CRO) and Good Manufacturing Practices (GMP) manufacturing facility, BDD offers a level of responsiveness and adaptability that larger CROs cannot match.

Services include:
– 505(b)(2)
– Clinical Trials Management
– Clinical Trials
– Contract Development and Manufacturing (CDMO)
– Contract Research (CRO)
– Dosage Form Development
– Feasibility Studies
– Process Development
– Formulation Development
– Controlled Release
– Imaging
– In Vitro Testing
– Testing
– Sustained Release Delivery Systems
– Regulatory Services
– Clinical Dose
– Small Molecule
– Drug Product Formulation (FDF)
– Research & Development
– Clinical Trial Materials

In conclusion, BDD is committed to optimising drug products for clinical success while delivering tailored services to meet the unique needs of clients in the pharmaceutical sector. For more information, please visit bddpharma.com.